Vioxx complaints tip of the iceberg, claims legal firm

COMPLAINTS received by the Irish Medicines Board (IMB) about the controversial arthritis drug Vioxx are only the tip of the iceberg, an Irish law firm has maintained.

Tue, 22 Feb, 2005 - 00:00
Evelyn Ring

Raymond Bradley of Malcomson Law says US statistics suggest about 500 people in Ireland are likely to have developed heart, stroke or kidney problems as a result of using the drug.

He is also surprised the IMB received just eight reports of cardiovascular- type reactions to Vioxx, first licensed here in 1999.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

In the Hospital Sick Male Patient Sleeps on the Bed. Heart Rate Monitor Equipment is on His Finger. 'Significant change' for better in mental health services
School closures for heat could now be more likely than snow days School closures for heat could now be more likely than snow days
Desperate Woman Homeless figures still at 'deeply alarming level' despite slight fall in numbers, charities warn
CourtsPlace: USPlace: IrelandPlace: CarlowPlace: DublinPerson: Raymond BradleyPerson: MerckPerson: BradleyOrganisation: VioxxOrganisation: ComplaintsOrganisation: Irish Medicines BoardOrganisation: IMBOrganisation: MalcomsonOrganisation: MerckOrganisation: Lieff CabraserOrganisation: Irish Medical NewsOrganisation: US Food and Drug AdministrationOrganisation: FDAOrganisation: Pfizer
<p>Health minister Jennifer Carroll MacNeill said she had asked for additional time to be given to the scoping exercise. Picture: Marc O’Sullivan</p>

Scoliosis patient group withdraws from planned inquiry into children’s care

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited